BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 1826545)

  • 41. Immunohistochemical detection of blood-retinal barrier breakdown in streptozotocin-diabetic rats.
    Murata T; Ishibashi T; Inomata H
    Graefes Arch Clin Exp Ophthalmol; 1993 Mar; 231(3):175-7. PubMed ID: 8462892
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prolactin levels in streptozotocin-induced diabetic rats.
    Kampa IS; Rosenberg JM; Sideman M; Kampa LL
    Horm Metab Res; 1986 Jun; 18(6):419-20. PubMed ID: 2942449
    [No Abstract]   [Full Text] [Related]  

  • 43. The effect of diabetes on transport through the blood-retinal and blood-brain barriers in rats.
    Taarnhöj J; Alm A
    Graefes Arch Clin Exp Ophthalmol; 1991; 229(3):291-3. PubMed ID: 1831178
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pathophysiology of the blood-retinal barrier in experimental diabetes. Vitreous fluorophotometry using carboxyfluorescein and fluorescein.
    Blair NP; Jones CW; Rusin MM
    Arch Ophthalmol; 1984 Dec; 102(12):1810-4. PubMed ID: 6508620
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Alteration of the blood-retinal barrier in experimental diabetes mellitus.
    Waltman S; Krupin T; Hanish S; Oestrich C; Becker B
    Arch Ophthalmol; 1978 May; 96(5):878-9. PubMed ID: 655925
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reproducibility of vitreous fluorophotometry in patients with type 1 diabetes mellitus.
    Jager J; Tromp A; Hooymans JM; Reitsma WD; Smit AJ
    Ophthalmologica; 1997; 211(4):209-13. PubMed ID: 9216008
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Calcein: a new dye for evaluation of the blood-retinal barrier by fluorophotometry.
    Golshani MR; Khoobehi B; Peyman GA
    Int Ophthalmol; 1993-1994; 17(6):349-53. PubMed ID: 8063478
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vitreous fluorophotometry and changes in blood-retinal barrier permeability induced by bendazac lysine.
    Nuzzi G; Venturini I; De Gregorio M; Arsenio L; Maraini G
    Acta Ophthalmol Scand; 1997 Feb; 75(1):41-3. PubMed ID: 9088399
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of aminoguanidine on the generation of superoxide anion and nitric oxide by peripheral blood granulocytes of rats with streptozotocin-induced diabetes.
    Kedziora-Kornatowska KZ; Luciak M; Błaszczyk J; Pawlak W
    Clin Chim Acta; 1998 Nov; 278(1):45-53. PubMed ID: 9877123
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fluorometric studies on the blood-retinal barrier in experimental animals.
    Krupin T; Waltman SR; Szewczyk P; Koloms B; Farber M; Silverstein B; Becker B
    Arch Ophthalmol; 1982 Apr; 100(4):631-4. PubMed ID: 6176219
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nonenzymatic glycosylation of vitreous proteins in vitro and in the streptozotocin-treated diabetic rat.
    Shires TK; Faeth JA; Pulido JS
    Retina; 1990; 10(2):153-8. PubMed ID: 2144905
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Vitreous fluorophotometry in diabetes mellitus.
    Krupin T; Waltman SR; Becker B
    Ophthalmology; 1979 Jan; 86(1):137-41. PubMed ID: 119199
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Blood-ocular and blood-brain barrier function in streptozocin-induced diabetes in rats.
    Mäepea O; Karlsson C; Alm A
    Arch Ophthalmol; 1984 Sep; 102(9):1366-9. PubMed ID: 6236780
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Perfluorocarbon effects on rabbit blood-retinal barrier permeability.
    Green K; Slagle T; Chaknis MJ; Cheeks L; Chang S
    Ophthalmic Res; 1993; 25(3):186-91. PubMed ID: 8336905
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Permeability of the blood-ocular barrier to mannitol and PAH during experimental diabetes.
    Ennis SR
    Curr Eye Res; 1990 Sep; 9(9):827-38. PubMed ID: 2123146
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Effect of tetromethylpyrazine and aminoguanidine on expression of vascular endothelial growth factor in kidney of diabetic rats].
    Huang Y; Chen SQ; Zhang G; Chen RH
    Zhong Xi Yi Jie He Xue Bao; 2004 Jan; 2(1):39-41. PubMed ID: 15339503
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Potentiating effect of glibenclamide on the occurrence of streptozotocin diabetes.
    Ikeda T; Takeuchi T; Ito Y; Murakami I; Mokuda O; Tominaga M; Mashiba H
    Horm Metab Res; 1986 May; 18(5):352. PubMed ID: 2941353
    [No Abstract]   [Full Text] [Related]  

  • 58. Carboxyfluorescein distribution in ocular tissues of normal and diabetic rats.
    Grimes PA
    Curr Eye Res; 1988 Oct; 7(10):981-8. PubMed ID: 2976362
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Protein levels in the vitreous of rats with streptozotocin-induced diabetes mellitus.
    Shires TK; Faeth JA; Pulido JS
    Brain Res Bull; 1993; 30(1-2):85-90. PubMed ID: 8420639
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antihistamines reverse blood-ocular barrier breakdown in experimental diabetes.
    Hollis TM; Gardner TW; Vergis GJ; Kirbo BJ; Butler C; Dull RO; Campos MJ; Enea NA
    J Diabet Complications; 1988; 2(1):47-9. PubMed ID: 2898479
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.